BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30632835)

  • 41. Sentinel case of Richter transformation from chronic lymphocytic leukaemia/small lymphocytic lymphoma to CD3+ diffuse large B-cell lymphoma.
    Ismail A; Mallick JA; Qin D; Hussaini MO
    J Clin Pathol; 2017 Jul; 70(7):575-578. PubMed ID: 27899414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
    Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
    J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonal IgH gene rearrangements identify Richter's transformation to diffuse large B cell lymphoma.
    Dalela D; Bledsoe JR; Patel SA
    Ann Hematol; 2021 Dec; 100(12):3075-3077. PubMed ID: 33159568
    [No Abstract]   [Full Text] [Related]  

  • 44. Transformation in Low-grade B-cell Neoplasms.
    Montgomery ND; Mathews SP
    Surg Pathol Clin; 2016 Mar; 9(1):79-92. PubMed ID: 26940269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?
    Aydin S; Rossi D; Bergui L; D'Arena G; Ferrero E; Bonello L; Omedé P; Novero D; Morabito F; Carbone A; Gaidano G; Malavasi F; Deaglio S
    Blood; 2008 Jun; 111(12):5646-53. PubMed ID: 18424664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The involvement of microRNA in the pathogenesis of Richter syndrome.
    Van Roosbroeck K; Bayraktar R; Calin S; Bloehdorn J; Dragomir MP; Okubo K; Bertilaccio MTS; Zupo S; You MJ; Gaidano G; Rossi D; Chen SS; Chiorazzi N; Thompson PA; Ferrajoli A; Bertoni F; Stilgenbauer S; Keating MJ; Calin GA
    Haematologica; 2019 May; 104(5):1004-1015. PubMed ID: 30409799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Richter Transformation of Chronic Lymphocytic Leukemia-Are We Making Progress?
    Audil HY; Kosydar SR; Larson DP; Parikh SA
    Curr Hematol Malig Rep; 2023 Oct; 18(5):144-157. PubMed ID: 37294394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study.
    Ramassone A; D'Argenio A; Veronese A; Basti A; Soliman SHA; Volinia S; Bassi C; Pagotto S; Ferracin M; Lupini L; Saccenti E; Balatti V; Pepe F; Rassenti LZ; Innocenti I; Autore F; Marzetti L; Mariani-Costantini R; Kipps TJ; Negrini M; Laurenti L; Visone R
    J Hematol Oncol; 2019 Nov; 12(1):114. PubMed ID: 31744508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Richter syndrome.
    Rossi D; Gaidano G
    Adv Exp Med Biol; 2013; 792():173-91. PubMed ID: 24014297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.
    Chastain EC; Duncavage EJ
    Arch Pathol Lab Med; 2015 May; 139(5):602-7. PubMed ID: 25248094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.
    Rossi D; Spina V; Forconi F; Capello D; Fangazio M; Rasi S; Martini M; Gattei V; Ramponi A; Larocca LM; Bertoni F; Gaidano G
    Int J Cancer; 2012 Jun; 130(12):3006-10. PubMed ID: 21796624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Richter transformation of chronic lymphocytic leukemia presenting as a dural-based non-hodgkin lymphoma mass.
    Ghofrani M; Tantiwongkosi B; Smith AS; Wasdahl DA
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):318-20. PubMed ID: 17297005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Revisiting Richter transformation in the era of novel CLL agents.
    Petrackova A; Turcsanyi P; Papajik T; Kriegova E
    Blood Rev; 2021 Sep; 49():100824. PubMed ID: 33775465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive markers and driving factors behind Richter syndrome development.
    Fangazio M; De Paoli L; Rossi D; Gaidano G
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):433-42. PubMed ID: 21417856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.
    Leeksma AC; Taylor J; Wu B; Gardner JR; He J; Nahas M; Gonen M; Alemayehu WG; Te Raa D; Walther T; Hüllein J; Dietrich S; Claus R; de Boer F; de Heer K; Dubois J; Dampmann M; Dürig J; van Oers MHJ; Geisler CH; Eldering E; Levine RL; Miller V; Mughal T; Lamanna N; Frattini MG; Heaney ML; Zelenetz A; Zenz T; Abdel-Wahab O; Kater AP
    Leukemia; 2019 Feb; 33(2):390-402. PubMed ID: 30038380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A rare case of empyema. Answer: Transformation of CLL into diffuse large B-cell lymphoma, also known as Richter syndrome.
    Yager NM; Ghate K; Swan RL; Farrokh A; Barba K; Beegle SH
    Chest; 2013 Jul; 144(1):350-353. PubMed ID: 23880686
    [No Abstract]   [Full Text] [Related]  

  • 57. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
    Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
    Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clonal evolution of Richter transformation cells uncovers therapeutic vulnerabilities.
    Nat Med; 2022 Aug; 28(8):1546-1547. PubMed ID: 35953722
    [No Abstract]   [Full Text] [Related]  

  • 59. Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.
    Vaisitti T; Braggio E; Allan JN; Arruga F; Serra S; Zamò A; Tam W; Chadburn A; Furman RR; Deaglio S
    Cancer Res; 2018 Jul; 78(13):3413-3420. PubMed ID: 29735551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
    Parry EM; Leshchiner I; Guièze R; Johnson C; Tausch E; Parikh SA; Lemvigh C; Broséus J; Hergalant S; Messer C; Utro F; Levovitz C; Rhrissorrakrai K; Li L; Rosebrock D; Yin S; Deng S; Slowik K; Jacobs R; Huang T; Li S; Fell G; Redd R; Lin Z; Knisbacher BA; Livitz D; Schneider C; Ruthen N; Elagina L; Taylor-Weiner A; Persaud B; Martinez A; Fernandes SM; Purroy N; Anandappa AJ; Ma J; Hess J; Rassenti LZ; Kipps TJ; Jain N; Wierda W; Cymbalista F; Feugier P; Kay NE; Livak KJ; Danysh BP; Stewart C; Neuberg D; Davids MS; Brown JR; Parida L; Stilgenbauer S; Getz G; Wu CJ
    Nat Med; 2023 Jan; 29(1):158-169. PubMed ID: 36624313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.